# REPOXEGEN THERAPEUTICS, INC: Targeting fatty acid metabolic disequilibrium-mediated neuroinflammation asa novel treatment for Alzheimer's disease

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | REPOXEGEN THERAPEUTICS, INC |
| Location | LOS ALTOS HILLS, CA |
| Project | Targeting fatty acid metabolic disequilibrium-mediated neuroinflammation asa novel treatment for Alzheimer's disease |
| Project number | 1R44AG099457-01A1 |
| Mechanism | R44 |
| Institute | National Institute on Aging |
| Award | $1,199,745 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-22 to 2029-02-28 |
| UEI | VMBPKKEESTN1 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11407457). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.